These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6188770)

  • 1. Terbutaline modulation of human allergic skin reactions.
    Ting S; Zweiman B; Lavker R
    J Allergy Clin Immunol; 1983 May; 71(5):437-41. PubMed ID: 6188770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of terbutaline and bambuterol on immediate-type allergic skin responses and mediator release in human skin.
    Petersen LJ; Skov PS
    Inflamm Res; 2003 Sep; 52(9):372-7. PubMed ID: 14504664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological support of antagonism of allergen-induced mast cell mediator release in human skin by a beta-2-agonist.
    Grönneberg R; Lagerholm B
    Allergy; 1986 Jan; 41(1):71-4. PubMed ID: 2421600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 2. Effect on the late phase reaction.
    Grönneberg R; Zetterström O
    Allergy; 1990 Jul; 45(5):340-6. PubMed ID: 2165750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of terbutaline on cutaneous responses in man to rechallenge with allergen and compound 48/80.
    Grönneberg R; Strandberg K
    Allergy; 1981 Jan; 36(1):33-8. PubMed ID: 7224109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cromolyn does not modulate human allergic skin reactions in vivo.
    Ting S; Zweiman B; Lavker RM
    J Allergy Clin Immunol; 1983 Jan; 71(1 Pt 1):12-7. PubMed ID: 6185553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of mast cell alterations and in vivo mediator release in human allergic skin reactions.
    Ting S; Dunsky EH; Lavker RM; Zweiman B
    J Allergy Clin Immunol; 1980 Nov; 66(5):417-23. PubMed ID: 6160172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of terbutaline, a beta 2-adrenergic receptor stimulating compound, on cutaneous reponses to histamine, allergen, compound 48/80, and trypsin.
    Grönneberg R; Strandberg K; Hägermark O
    Allergy; 1979 Oct; 34(5):303-9. PubMed ID: 44669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine suppression of in vivo eosinophil accumulation and histamine release in human allergic reactions.
    Ting S; Zweiman B; Lavker R; Dunsky EH
    J Allergy Clin Immunol; 1981 Jul; 68(1):65-71. PubMed ID: 6165750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cromolyn on codeine-induced histamine release in vivo.
    Ting S; Reimann EF; Zweiman B
    Allergy; 1984 Oct; 39(7):493-7. PubMed ID: 6208804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of anti-IgE induced skin response in normals by formoterol, a new beta 2-adrenoceptor agonist, and terbutaline. 1. Dose response relation and duration of effect on the early wheal and flare response.
    Grönneberg R; Zetterström O
    Allergy; 1990 Jul; 45(5):334-9. PubMed ID: 1974124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of Verapamil in inhibiting allergen-induced histamine release in vivo.
    Ting S; Mansfield LE; Rauls DO
    Allergy; 1985 Oct; 40(7):519-22. PubMed ID: 2416233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions.
    Zweiman B; Atkins PC; von Allmen C; Gleich GJ
    J Allergy Clin Immunol; 1991 May; 87(5):984-92. PubMed ID: 1709185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equivalent inhibition by terbutaline of anti-human IgE skin responses in atopic and non-atopic subjects.
    Grönneberg R; Strandberg K; Stålenheim G; Zetterström O
    Allergy; 1985 Jan; 40(1):27-35. PubMed ID: 2579597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal patterns of mediator release during developing cutaneous late-phase reactions.
    Zweiman B; Von Allmen C
    Clin Exp Allergy; 2000 Jun; 30(6):856-62. PubMed ID: 10848904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect in man of anti-allergic drugs on the immediate and late phase cutaneous allergic reactions induced by anti-IgE.
    Grönneberg R; Strandberg K; Stålenheim G; Zetterström O
    Allergy; 1981 Apr; 36(3):201-8. PubMed ID: 7195156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular inflammatory responses during immediate, developing, and established late-phase allergic cutaneous reactions: effects of cetirizine.
    Zweiman B; Atkins PC; Moskovitz A; von Allmen C; Ciliberti M; Grossman S
    J Allergy Clin Immunol; 1997 Sep; 100(3):341-7. PubMed ID: 9314346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of formoterol and terbutaline on the development of late phase skin reactions.
    Grönneberg R; Zetterström O
    Clin Exp Allergy; 1992 Feb; 22(2):257-63. PubMed ID: 1349258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effect of hydroxyzine on antigen-induced histamine release in vivo.
    Ting S; Rauls DO; Reiman BE
    J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):63-6. PubMed ID: 2578493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terbutaline's effects on the allergy skin test.
    Imbeau SA; Harruff R; Hirscher M; Reed CE
    J Allergy Clin Immunol; 1978 Oct; 62(4):193-6. PubMed ID: 359625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.